Abstract: This disclosure describes compounds of the class of 15-substituted-9-keto(or 9-hydroxy)prostanoic acids and the esters and cationic salts thereof, useful as inhibitors of gastric acid secretion.
Type:
Grant
Filed:
October 24, 1975
Date of Patent:
September 6, 1977
Assignee:
American Cyanamid Company
Inventors:
Robert Eugene Schaub, Martin Joseph Weiss
Abstract: The compounds, 11-(4-piperidyl)-5H-dibenzo[b,e] [1,4]diazepines, intermediates and methods of preparation thereof are described. They are useful as neuroleptic agents.
Type:
Grant
Filed:
December 14, 1975
Date of Patent:
August 30, 1977
Assignee:
American Cyanamid Company
Inventors:
Robert Allis Hardy, Jr., Nicanor Quinones Quinones
Abstract: This disclosure describes homologues, analogues, congeners, and derivatives of 9-oxo-13-trans-prostenoic acid and of 9-hydroxy-13-trans-prostenoic acid, having antimicrobial activity and prostaglandin-like hypotensive activity.
Type:
Grant
Filed:
May 5, 1975
Date of Patent:
August 23, 1977
Assignee:
American Cyanamid Company
Inventors:
Karel Francis Bernady, Middleton Brawner Floyd, Jr., John Frank Poletto, Robert Eugene Schaub, Martin Joseph Weiss
Abstract: This disclosure describes a process for the recovery of 7-dimethylamino-6-demethyl-6-deoxytetracycline from an aqueous solution thereof by means of a calcium chloride complex of 7-dimethylamino-6-demethyl-6-deoxy-tetracycline hydrochloride.
Abstract: This disclosure describes novel 2,5-dihydro-2,5-dialkoxyfuran derivatives useful as intermediates for the preparation of the natural prostaglandins and their congeners.
Abstract: A sustained release depot form of the free base or pamoate salt of 2-chloro-11-(1-piperazinyl)-dibenz[b,f][1,4]-oxazepine or 2-chloro-11-(4-methyl-1-piperazinyl)-dibenz[b,f]-[1,4]oxazepine in an injectable oil for parenteral administration.
Type:
Grant
Filed:
July 16, 1975
Date of Patent:
April 5, 1977
Assignee:
American Cyanamid Company
Inventors:
George Madison Sieger, James Elwood Krueger, Arnold Curtis Osterberg, David Henry Tedeschi
Abstract: 9-Aminoalkyl-4,9-dihydro-10H-thieno[3,4-b][1,5]benzodiazepin-10-ones having anti-depressant and analgesic activity and which are intermediates for other compounds having central nervous system activity.
Abstract: This disclosure describes certain 1-alkoximino-2-(.omega.-substituted-alkyl)-2-cyclopentenes useful as intermediates for the preparation of homologues, analogues, congeners, and derivatives of 9-oxo-13-trans-prostenoic acid and of 9-hydroxy-13-trans-prostenoic acid which have antimicrobial activity and prostaglandin-like hypotensive activity.
Type:
Grant
Filed:
February 24, 1975
Date of Patent:
February 1, 1977
Assignee:
American Cyanamid Company
Inventors:
Karel Francis Bernady, John Frank Poletto, Martin Joseph Weiss
Abstract: This invention relates to novel substituted 4,5,6,7-tetrahydro-7-oxybenzo[b]thien-4-ylurea compounds and a process for the preparation thereof. The compounds of this invention are useful as herbicidal agents and animal growth regulants.
Abstract: The present invention relates to 4,5,6,7-tetrahydro-7-oxobenzo[b]thien-4-yl isocyanate and isothiocyanate, which are novel and useful intermediates for the preparation of 4,5,6,7-tetrahydro-7-oxobenzo[b]thien-4-ylurea and thiourea compounds which are animal growth promoters.The present invention also relates to methods of preparation for the above-identified thienyl isocyanates and isothiocyanates.
Abstract: This invention relates to 1,2,3,4-tetrahydro-4-oxo-1-naphthylisocyanate and- isothiocyanate and to methods of preparation of said compounds.The compounds of the present invention are useful as intermediates for the preparation of 1,2,3,4-tetrahydro-4-oxo(oxy)-1-naphthylurea and- thiourea compounds and certain derivatives thereof. The naphthylurea and thiourea compounds are animal growth regulators and herbicides.
Abstract: The preparation of 1-amino-3-(4- and 3,4-substituted benzylideneamino)guanidine and the acid addition salts thereof, and their use as intermediates in the preparation of 1,3-bis-(4- and 3,4-substituted benzylideneamino)guanidines and their acid addition salts.The final compounds prepared from the present intermediates have antiprotozoal activity particularly against coccidiosis and malaria.
Abstract: This invention relates to a method for the control of helminths in homothermic domestic and farm animals by administering to said animals on anthelmintically effective amount of a benzopyran compound.
Abstract: The preparation of compounds of the type 6-(mono substituted phenyl)-5,6-dihydro or 2,3,5,6-tetrahydroimidazo[2,1-b]thiazoles and the pharmaceutically acceptable salts thereof, is described. The use of said compounds for treating helminthiasis in warm-blooded animals is also described.
Abstract: This disclosure describes a novel class of antibiotics, three of which have been designed AM31.alpha., AM31.beta., and AM31.gamma. and are produced in a microbiological fermentation under controlled conditions using a new strain of Streptoverticillium netropsis.
Type:
Grant
Filed:
March 19, 1975
Date of Patent:
October 19, 1976
Assignee:
American Cyanamid Company
Inventors:
Jane Parsons Kirby, Donald Bruce Borders
Abstract: The compounds 1,2,3,11a-tetrahydro-10-methyl-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5,11(10 H)-dione and 7-fluoro-1,2,3,11a-tetrahydro-10-methyl-5H-pyrrolo[2,1-c][1,4]benzodiazepi n-5,11(10H)-dione in the form of their dextrorotatory isomers and as racemic mixtures, their method of preparation and method of use are described. The compounds in their different forms are useful in treating anxiety in warm-blooded animals.
Abstract: This invention resides in the field of p-fluorobenzoylpropyl-N-heterocyclic substituted quaternary salts useful as intermediates in the preparation of 1-p-fluorophenyl-4-N-heterocyclic-1-butanols, 1-p-fluorophenyl-4-N-heterocyclic-1-butanol esters and p-fluoro-.gamma.-heterocyclic butyrophenones having neuroleptic and analgesic activity. The butanols, butanol esters and butyrophenones from the subject matter of our concurrently filed and co-pending application Ser. No. 575,846, filed May 8, 1975, incorporated herein by reference.
Type:
Grant
Filed:
May 8, 1975
Date of Patent:
October 12, 1976
Assignee:
American Cyanamid Company
Inventors:
Corris Mabelle Hofmann, Sidney Robert Safir
Abstract: Aminoacyl derivatives of 2,3,5,10,11,11a-hexahydro-1H-pyrrolo[2,1-c] [1,4]benzodiazepines in the form of their racemic mixtures, optical isomers and salts, their method of preparation and method of use are described. The compounds are useful in treating anxiety in warm-blooded animals.
Abstract: A superior grade of 1,3-bis(4-chlorobenzylideneamino)-guanidine hydrochloride is obtained by dispersing crude material in a suitable solvent, slowly adding to the dispersion an amount of base at least equivalent to the number of moles of 1,2,3-tris(4-chlorobenzylideneamino)guanidine hydrochloride present in said crude 1,3-bis(4-chlorobenzylideneamino)guanidine hydrochloride, separating the purified 1,3-bis(4-chlorobenzylideneamino)guandidine hydrochloride therefrom, and washing and drying the same.